Jody Hessen, RPh Clinical Consultant

FDA Approvals

FDA Approves Alzheimer’s Drug: Aduhelm

*Co-Authored By: Brian Maas, RPh Clinical Consultant

Read More

Breaking Down Barriers to Cancer Treatment: Problems and Solutions

Introduction Cancer is the second most common cause of death in the US1, and one of the most feared. Its effects can be devastating–physically, emotio...

Read More
Hemophilia | Treatments

The High Cost of Hemophilia A Treatments

Managing the costs of a rare and complex disease What is Hemophilia A? Hemophilia A is a rare, chronic, inherited disease that occurs in about 1 of ev...

Read More
Healthcare | Brand vs. Generic

Are Brand-Name Drugs Safer Than Generics?

In 2019, Katherine Eban published a book, “Bottle of Lies”. It tells a convincing story that leaves readers concluding that all generic drugs are bad....

Read More
Brand vs. Generic | HIV

Navigating HIV PrEP and the Affordable Care Act

What is PrEP PrEP is short for Pre-Exposure Prophylaxis and is used as a preventative medication of HIV infection. The virus-killing medication is tak...

Read More
Healthcare | Drug Pricing

Updated executive order on drug pricing, signed by President Trump

*Co-Authored By: Thatcher Sloan, Vice President, Practice Leader What You Need to Know

Read More